Your browser doesn't support javascript.
loading
Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers.
Schadendorf, Dirk; Robert, Caroline; Dummer, Reinhard; Flaherty, Keith T; Tawbi, Hussein A; Menzies, Alexander M; Banerjee, Hiya; Lau, Mike; Long, Georgina V.
Affiliation
  • Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. Electronic address: dirk.schadendorf@uk-essen.de.
  • Robert C; Dermatology Service and Melanoma Research Unit, Gustave Roussy, Villejuif, France; Paris-Saclay University, Orsay, France.
  • Dummer R; Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland.
  • Flaherty KT; Dana-Farber Cancer Institute/Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA.
  • Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Menzies AM; Department of Medical Oncology, Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
  • Banerjee H; Clinical Development and Analytics, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Lau M; Global Medical Affairs, Novartis Pharma AG, Basel, Switzerland.
  • Long GV; Department of Medical Oncology, Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
Eur J Cancer ; 153: 234-241, 2021 08.
Article in En | MEDLINE | ID: mdl-34225229

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oximes / Pyridones / Pyrimidinones / Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins B-raf / Fever / Imidazoles / Neoplasms Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oximes / Pyridones / Pyrimidinones / Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins B-raf / Fever / Imidazoles / Neoplasms Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2021 Document type: Article Country of publication: